SLU-PP-332 research: what the studies show

SLU-PP-332 is a synthetic molecule that switches on all three estrogen-related receptors and is studied as an exercise mimetic. The published work to date is laboratory research in cells and mice, and here is what it found.

Findings

  • In mice, SLU-PP-332 increased type IIa oxidative muscle fibres and enhanced exercise endurance, switching on the same acute aerobic exercise gene programme as a workout.
  • In obese mice it increased energy expenditure and fat oxidation, reduced fat mass and improved insulin sensitivity.
  • In a heart failure model it significantly improved ejection fraction, reduced fibrosis and increased survival, without changing heart size.
  • Eight weeks of treatment in 21-month-old mice reversed age-related rises in albuminuria and podocyte loss in the kidney.
  • The muscle effect depended on ERR-alpha and the heart effect on ERR-gamma, confirmed by genetic dependency experiments.

Endurance and muscle fibre type (ACS Chem Biol, 2023)

The team that designed the molecule reported it as a pan agonist of the three estrogen-related receptors, with the highest potency at ERR-alpha, and with pharmacokinetic properties good enough to use as a chemical tool in living animals. In a skeletal muscle cell line it increased mitochondrial function and cellular respiration. In mice it increased the proportion of type IIa oxidative muscle fibres and enhanced exercise endurance. Switching off ERR-alpha removed the endurance benefit, which is how the authors established that the receptor was doing the work rather than some side effect of the molecule.

Obesity and metabolic syndrome (J Pharmacol Exp Ther, 2024)

Diet-induced obese mice and genetically obese ob/ob mice were given SLU-PP-332. Whole-body metabolism shifted the way it shifts with exercise: energy expenditure rose and fatty acid oxidation increased, and fat mass accumulation fell. In the metabolic syndrome models the compound reduced obesity and improved insulin sensitivity. The authors concluded that activating these receptors pharmacologically may be an effective route to treating metabolic disease, and framed the molecule as an exercise mimetic that decreases fat mass.

Heart failure: ejection fraction and survival (Circulation, 2024)

In mice with heart failure induced by pressure overload, SLU-PP-332 and a related compound significantly improved ejection fraction, reduced fibrosis and increased survival, without affecting the thickening of the heart muscle. Gene and metabolite profiling showed broad activation of fatty acid metabolism and mitochondrial genes, and metabolite profiles in the overloaded heart moved back toward normal after six weeks. Genetic dependency work identified ERR-gamma as the receptor mediating the cardiac protection.

The aging kidney (Am J Pathol, 2023)

Estrogen-related receptors decline in aging human and mouse kidneys, and stay higher in mice kept on lifelong caloric restriction. Treating 21-month-old mice with a pan-ERR agonist for eight weeks reversed the age-related increases in albuminuria, podocyte loss, mitochondrial dysfunction and inflammatory cytokines, through the cGAS-STING and STAT3 signalling pathways. The authors described these receptors as caloric-restriction mimetics on this evidence.

What SLU-PP-332 is

SLU-PP-332 is a synthetic small molecule, not a peptide, that activates ERR-alpha, ERR-beta and ERR-gamma. Those three receptors sit upstream of the genes that control how muscle, heart and kidney cells burn fuel and build mitochondria, which is why one compound produces results across such different tissues in the studies above. Our reconstitution guide covers handling of research material supplied as a lyophilised powder.

Vistara Labs stocks SLU-PP-332 research vials, shipped from within Canada to every province.

Frequently asked questions

Has SLU-PP-332 been studied in humans?

No. The published work to date is laboratory research in cells and in mice. There are no human trials of SLU-PP-332, so every figure on this page comes from animal or cell studies.

Why is SLU-PP-332 called an exercise mimetic?

Because in mice it switched on the same genetic programme that a bout of aerobic exercise switches on. Treated mice gained type IIa oxidative muscle fibres and ran longer, and the effect depended on the ERR-alpha receptor.

What is SLU-PP-332?

SLU-PP-332 is a synthetic small molecule that activates all three estrogen-related receptors, ERR-alpha, ERR-beta and ERR-gamma, with the highest potency at ERR-alpha. These receptors regulate how muscle and heart cells use fuel.

Sources: Billon C, et al. Synthetic ERR alpha/beta/gamma agonist induces an ERR alpha-dependent acute aerobic exercise response and enhances exercise capacity. ACS Chem Biol. 2023;18:756-71. PMID 36988910. Billon C, et al. A synthetic ERR agonist alleviates metabolic syndrome. J Pharmacol Exp Ther. 2024;388:232-40. PMID 37739806. Xu W, et al. Novel pan-ERR agonists ameliorate heart failure through enhancing cardiac fatty acid metabolism and mitochondrial function. Circulation. 2024;149:227-50. PMID 37961903. Wang XX, et al. Estrogen-related receptor agonism reverses mitochondrial dysfunction and inflammation in the aging kidney. Am J Pathol. 2023;193:1969-87. PMID 37717940.

All products supplied by Vistara Labs are intended for laboratory research use only. They are not drugs, are not approved for human or veterinary use, and are not intended to diagnose, treat, cure or prevent any condition. Nothing on this page constitutes medical advice or guidance for use in humans.

Similar Posts